Add time:08/17/2019         Source:sciencedirect.com

DPP-IV inhibitors have been immersed as promising pathway to treat Type 2 diabetes. Here we have reported designing of coumarin derivatives as DPP-IV inhibitors. Designed compounds have been studied for their binding with DPP-IV enzyme through molecular docking followed by synthesis. All synthesized compounds have been fully characterized and screened for DPP-IV inhibition activity. Two compounds showed very good inhibition at 10 μM concentration.

We also recommend Trading Suppliers and Manufacturers of METHYL 6-BROMO-4-OXO-4H-CHROMENE-2-CARBOXYLATE (cas 116543-92-1). Pls Click Website Link as below: cas 116543-92-1 suppliers